Form 4: Envoy Medical Director Acquires Shares Through In-Kind Distribution

Susan Kantor, a director at Envoy Medical, acquired 18,182 shares of Class A Common Stock through a pro-rata in-kind distribution.

Summary

• Susan Kantor, a director of Envoy Medical, acquired 18,182 shares of Class A Common Stock on November 19, 2024.
• The shares were received as part of a pro-rata in-kind distribution from Anzu SPAC GP I LLC to its members.
• No consideration was paid for the shares.
• Following the transaction, Ms. Kantor directly owns 43,182 shares of Envoy Medical Class A Common Stock.

Sentiment

Score: 6

Explanation: The document is a routine filing and does not indicate any significant positive or negative sentiment. It reflects a standard transaction.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company.

Industry Context

This is a standard SEC Form 4 filing, which is common for corporate insiders reporting changes in their beneficial ownership of company stock. It is a routine disclosure and does not indicate any unusual activity.

Comparison to Industry Standards

• Form 4 filings are a standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
• The in-kind distribution is a specific transaction type, and the reporting is in line with SEC guidelines for such events.
• Other companies with similar insider ownership structures would have similar filings when changes in ownership occur.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it shows a director's increased stake in the company.

Key Dates

Keywords

Form 4, Beneficial Ownership, Envoy Medical, Director, Class A Common Stock, In-Kind Distribution, Anzu SPAC GP I LLC, Susan Kantor